Opiate-induced analgesia is increased and prolonged in mice lacking P- glycoprotein

Anesthesiology

Volumn 92, Issue 5, 2000, Pages 1392-1399

  Thompson, Susan J ^a   Koszdin, Kari ^b   Bernards, Christopher M ^b  

^a Sacred Heart Children's Hospital   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Fentanyl; FVB; mdr1a 1b ( ); Meperidine; Methadone; Morphine 6 glucuronide

Indexed keywords

CYCLOSPORIN A; FENTANYL DERIVATIVE; GLYCOPROTEIN P; MEMBRANE PROTEIN; METHADONE; MORPHINE 6 GLUCURONIDE; MORPHINE DERIVATIVE; OPIATE; PETHIDINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD BRAIN BARRIER; CALCULATION; DRUG EFFECT; DRUG EFFICACY; DRUG SENSITIVITY; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

EID: 0034016617     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200005000-00030     Document Type: Article

References (18)

1. Trambas CM: P-glycoprotein mediated multidrug resistance and its implications for pathology. Pathology 1997; 29:122-30
2. Ginn P: Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues. Vet Pathol 1996; 33:533-41
3. Sugawara I: Expression and function of P-glycoprotein (mdr1 gene product) in normal and malignant tissues. Acta Pathol Jpn 1990; 40:545-53
4. van der Valk P, van Kalken CK, Ketelaars H, Broxterman HJ, Scheffer G, Kuiper CM, Tsuruo T, Lankelma J, Meijer CJ, Pinedo HM: Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues: Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule. Ann Oncol 1990; 1:56-64
5. Beaulieu E, Demeule M, Pouliot J-F, Averill-Bates DA, Murphy GF, Beliveau R: P-glycoprotein of blood brain barrier: Cross-reactivity of MAb C219 with a kDa protein in bovine and rat isolated brain capillaries. Biochim Biophys Acta 1995; 1233:27-32
6. Lankas GR, Cartwright ME, Umbenhauer D: P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity. Toxicol Appl Pharmacol 1997; 143:357-65
7. Golden PL, Pardridge WM: P-glycoprotein on astrocyte foot processes of unfixed isolated human brain capillaries. Brain Res 1999; 819:143-6
8. Callaghan R, Riordan JR: Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells. J Biol Chem 1993; 268:16059-64
9. Huwyler J, Drewe J, Gutmann H, Thole M, Flicker G: Modulation of morphine-6-glucuronide penetration into the brain by P-glycoprotein. Int J Clin Pharmacol Ther 1998; 36:69-70
10. Letrent SP, Pollack GM, Brouwer KR, Brouwer KL: Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat. Pharm Res 1998; 15:599-605
11. Schinkel AH, Wagenaar E, Mol CAAA, van Deemter L: P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 1996; 97:2517-24
12. Grinstead GF: A closer look at acetyl and pentafluoropropionnyl derivatives for quantitative analysis of morphine and codeine by gas chromatography/mass spectrometry. J Anal Toxicol 1991; 15:293-8
13. Ohnishi T, Tamai I, Sakanaka K, Sakata A, Yamashima T, Yamashita J, Tsuji A: In vivo and in vitro evidence for ATP-dependency of P-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrier. Biochem Pharmacol 1995; 49:1541-4
14. Schinkel AH, Wagenaar E, van Deemter L, Mol CAA, Borst P: Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 1995; 96:1698-705
15. Sikic BI: Pharmacologic approaches to reversing multidrug resistance. Semin Hematol 1997; 34:40-7
16. Sonneveld P, Wiemer E: Inhibitors of multidrug resistance. Curr Opin Oncol 1997; 9:543-8
17. Fardel O: Upregulation of P-glycoprotein in rat liver cells by acute doxorubicin treatment. Eur J Biochem 1997; 246:186-92
18. Su GM: Induction of broad drug resistance in small cell lung cancer cells and its reversal by paclitaxel. Int J Cancer 1998; 76:702-98